Company overview
Cell Microsystems provides innovative tools like the CellRaft AIR System for imaging, identifying, and isolating single cells and organoids, supporting applications in CRISPR gene editing, stem cell biology, cancer research, and cell line development. Their offerings include BioFlux Shear Flow Systems for physiological shear flow analysis and CERO 3D Cell Culture Bioreactor for long-term organoid growth. The company also delivers contract lab services for cell line development, custom organoid assays, and advanced analyses such as automated patch clamp.
Cell Microsystems is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include single cell isolation, cellraft technology, organoid development, cell line development, crispr tools.
Structured facts
- Website
- https://cellmicrosystems.com
- Markets served
- United States & Americas
- Keywords
- single cell isolation, cellraft technology, organoid development, cell line development, crispr tools
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What core technologies does Cell Microsystems offer for single cell workflows?
- Cell Microsystems offers the CellRaft AIR System for automated imaging, analysis, and isolation of single cells, colonies, and organoids using magnetic CellRaft arrays, along with BioFlux Shear Flow Systems and CERO 3D Bioreactor.
- What lab services are available from Cell Microsystems?
- Services include cell line and custom organoid development, assays using CellRaft Technology, cell analysis under shear flow, and automated patch clamp assays for ion channels.
- What research applications are supported by their products?
- Products support CRISPR gene editing, stem cell research, organoid studies, cell line development, antibody discovery, cancer research, immunology, neurobiology, and genomics.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
